Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Frontiers in Cell and Developmental Biology|July 18, 2022
Immuno-Modulatory Effects of Intervertebral Disc CellsPaola Bermudez-Lekerika, Katherine B Crump, Sofia Tseranidou, et al.
Cell Systems|July 16, 2018
Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS SignalingOleksii S Rukhlenko, Fahimeh Khorsand, Aleksandar Krstic, et al.
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
The European Respiratory Journal|August 11, 2007
Chemotherapy improves low performance status lung cancer patientsJ P Sculier, J J Lafitte, M Paesmans, et al.
Redox Biology|March 6, 2018
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insightsChristina Cheimonidi, Pinelopi Samara, Panagiotis Polychronopoulos, et al.
Molecular Systems Biology|February 18, 2026
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanismsCharlie George Barker, Sumana Sharma, Ana Mafalda Santos, et al.
Frontiers in Oncology|April 12, 2021
A Multi-Omics Analysis of Metastatic Melanoma Identifies a Germinal Center-Like Tumor Microenvironment in HLA-DR-Positive Tumor AreasLaura Gadeyne, Yannick Van Herck, Giorgia Milli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 13, 2014
Signaling networks in MS: a systems-based approach to developing new pharmacological therapiesEkaterina Kotelnikova, Marti Bernardo-Faura, Gilad Silberberg, et al.
Scientific Data|May 16, 2015
The species translation challenge-a systems biology perspective on human and rat bronchial epithelial cellsCarine Poussin, Carole Mathis, Leonidas G Alexopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)E Van Cutsem, D Cunningham, W W Ten Bokkel Huinink, et al.
Pageof 16